[
  {
    "publicationDate": "2025-10-01",
    "tradeTitle": "Short Put on MRNA",
    "summaryJustification": "Based on the analysis, MRNA is hovering above its 5-year low with a rising IV Rank of 49% ahead of earnings. A short put is a bullish strategy that leverages this high premium and market skew indicating upside risk.",
    "expectedReturnDisplay": "$80 Max Profit",
    "ticker": "MRNA",
    "currentPrice": 25.00,
    "ivRank": 49,
    "earningsDate": "Early November 2025",
    "analysis": {
      "thesis": "MRNA is down significantly for the year, but its improved product pipeline and market skew (OTM calls trading over puts) suggest optimism. With a high IV Rank of 49%, its options are rich. A short put allows a trader to express a bullish view and capitalize on the high premium, with the trade expiring before the early November earnings announcement to avoid binary event risk.",
      "strategyType": "Short Put",
      "tradeDetails": {
        "expiration": "2025-10-31",
        "dte": 30,
        "putStrike": 22.00,
        "putPremium": 0.80
      },
      "metrics": {
        "roc": 3.8,
        "annualizedRoc": 0.0,
        "pop": 87,
        "buyingPowerEffect": 2120
      },
      "managementPlan": "The analysis notes an 87% probability of achieving 50% of max profit, aligning with the standard management plan to target 50% profit or manage the trade near 21 DTE."
    }
  }
]